About Dr. Pothuri
Vikram Pothuri is a PGY-1 general surgery resident at the University of Pennsylvania. He completed his undergraduate studies in Molecular Biology and Computer Science at Princeton University before receiving his medical degree and master of population health sciences at Washington University School of Medicine in St. Louis. Vikram is currently interested in HPB, transplant, and surgical oncology.
Education
2019 - 2023
MD/MPHS – Washington University School of Medicine in St. Louis
2013 - 2017
AB – Princeton University
Societies
2021 - present
The Americas Hepato-Pancreato-Biliary Association (AHPBA)
2019 - present
Society of Surgical Oncology (SSO)
Awards
2024
Louis and Dorothy Kovitz Senior Prize in Surgery
2024
Robert Carter Medical School Award
2024
Antionette France Dames Award in Cell Biology and Physiology
2020
Washington University School of Medicine Summer Research Prize
2019
WUSM Distinguished Student Scholarship
2017
Cum Laude in Molecular Biology (Princeton University)
Research
During medical school, Vikram worked on several projects in the lab of Dr. Ryan C. Fields in collaboration with Dr. David DeNardo studying T-cells in patients with pancreatic ductal adenocarcinoma. This work used T-cell receptor signatures and tumor microenvironment features to predict overall survival and response to immune-based therapies. Additionally, as part of his master of population health sciences, he led research projects on the effects of sociodemographic factors on outcomes in pancreatic cancer, national utilization of minimally invasive approaches for liver resections, and shared decision-making in colorectal cancer.
Publications
Peer-Reviewed Articles
- Pothuri V, Hogg G, Conant L, Borcherding N, James CA, Mudd J, Williams G, Seo YD, Hawkins WG, Pillarisetty VG, Denardo DG, Fields RC (2023). Intratumoral T-cell Receptor Repertoire Composition Predicts Overall Survival in Patients with Pancreatic Ductal Adenocarcinoma. OncoImmunology. 2024 Mar 15; 13:1, DOI: 10.1080/2162402X.2024.2320411
- Pothuri V, Zarate Rodrigues JG, Kasting C, Leigh N, Hawkins WG, Sanford DE, Fields RC (2023). Area Deprivation and Rurality Impact Overall Survival and Adjuvant Therapy Administration in Patients with Pancreatic Ductal Adenocarcinoma (PDAC). HPB. 2023 Aug 17; https://doi.org/10.1016/j.hpb.2023.08.005.
- Pothuri V, Anzelmo M, Gallaher E, Ogunlana Y, Aliabadi-Wahle S, Tan B, Crippin J, Hammill C (2023). Transgender Males on Gender-Affirming Hormone Therapy and Hepatobiliary Neoplasms: A Systematic Review. Endocrine Practice. 2023 Jun 5; S1530-891X(23)00426-3. doi: 10.1016/j.eprac.2023.05.011.
- Pothuri V, Herndon J, Ballentine SJ, Lim KH, Fields RC. A Case of a Pathological Complete Response to Neoadjuvant Nivolumab plus Ipilimumab in Periampullary Adenocarcinoma. The Oncologist. 2021;26(9):722-726. doi:10.1002/onco.13821.
Podium Presentations
- Pothuri VS, Nickel KB, Abdelzaher A, Gani F, Fields RC, Joynt Maddox K, Butler AM, Hammill CW. (2024). National Trends in the Utilization of Minimally Invasive and Open Liver Resections. Academic Surgical Congress. Washington D.C.: February 8.
- Pothuri V, Kasting C, Zarate Rodriguez J, Leigh N, Sanford DE, Hawkins W, Fields RC. (2023). Area Deprivation and Rurality Impact Overall Survival and Adjuvant Therapy Administration In Patients With Pancreatic Ductal Adenocarcinoma (PDAC) Following Surgical Resection. American College of Surgeons Clinical Congress. Boston, MA: October 25.
- Pothuri V, Hogg G, Conant L, James A, Williams G, Hawkins W, DeNardo D, Fields RC. (2022). T-cell Receptor Repertoire Analysis Reveals Positive Correlation Between Intra-tumoral Clonotype Diversity and Overall Survival in Patients with Pancreatic Ductal Adenocarcinoma (*Multi-Institutional Cohort). International Hepato-Pancreato-Biliary Association. New York City, NY: March 31
- Pothuri V, Hogg G, Conant L, James A, Williams G, Hawkins W, DeNardo D, Fields RC. (2021). T-cell Receptor Repertoire Analysis Reveals Positive Correlation Between Intra-tumoral Clonotype Diversity and Overall Survival in Patients with Pancreatic Ductal Adenocarcinoma (*Multi-Institutional Cohort). Americas Hepato-Pancreato-Biliary Association. Miami, FL: August 2.
- Pothuri V, Hogg G, Conant L, James A, Williams G, DeNardo D, Fields RC. (2021). T-cell Receptor Repertoire Analysis Reveals Positive Correlation Between Intra-tumoral Clonotype Diversity and Overall Survival in Patients with Pancreatic Ductal Adenocarcinoma (*Single-Institutional Cohort). Society of Surgical Oncology International Conference on Surgical Cancer Care. March 18.
Poster Presentations
- Pothuri V, Nickel KB, Butler AM, Hammill CW (2023). Temporal Trends and Utilization of Minimally Invasive vs. Open Liver Resections. American Association for the Study of Liver Diseases (AASLD) The Liver Meeting. Boston, MA: November 10.
- Pothuri V, Hogg G, Conant L, James A, Williams G, DeNardo D, Fields RC. (2021). T-cell Receptor Repertoire Analysis Reveals Positive Correlation Between Intra-tumoral Clonotype Diversity and Overall Survival in Patients with Pancreatic Ductal Adenocarcinoma. Washington University Research Training Symposium. St. Louis, MO: October 6.